Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
J Behav Med. 2023 Apr;46(1-2):100-115. doi: 10.1007/s10865-022-00283-9. Epub 2022 Feb 2.
Determinants of parental HPV vaccine hesitancy, including medical mistrust and exposure to negative vaccine information, are understudied in racial/ethnic minority communities where vaccine uptake is low. We conducted a cross-sectional survey (March 2021) among parents of adolescents, ages 9-17 years, from an academic enrichment program serving low-income, first-generation, underrepresented minority families in Los Angeles to understand determinants of parental HPV vaccine hesitancy. Parents completed self-administered surveys, including a 9-item HPV vaccine hesitancy scale, in either English, Spanish, or Chinese. Logistic regression was used to identify individual and interpersonal factors associated with parental hesitancy and adolescent HPV vaccination. One-fifth of parents (n = 357) reported high HPV vaccine hesitancy and > 50% reported concerns about safety or side effects. High medical mistrust was associated with high parental HPV vaccine hesitancy (adjusted-OR 1.69, 95% CI: 1.13, 2.37). Community-tailored and multilevel strategies to increase vaccine confidence are needed to improve HPV and other adolescent vaccinations.
父母 HPV 疫苗犹豫的决定因素,包括对医疗的不信任和接触到负面疫苗信息,在疫苗接种率较低的少数族裔群体中研究得还不够。我们在洛杉矶的一个为低收入、第一代、代表性不足的少数族裔家庭服务的学术强化项目中,对青少年(9-17 岁)的父母进行了一项横断面调查(2021 年 3 月),以了解父母 HPV 疫苗犹豫的决定因素。父母们以英语、西班牙语或中文完成了自我管理的调查,其中包括 9 项 HPV 疫苗犹豫量表。使用逻辑回归来确定与父母犹豫和青少年 HPV 疫苗接种相关的个体和人际因素。五分之一的父母(n=357)报告了对 HPV 疫苗的高度犹豫,超过 50%的父母对安全性或副作用表示担忧。高度的医疗不信任与父母 HPV 疫苗犹豫呈正相关(调整后的比值比 1.69,95%置信区间:1.13,2.37)。需要制定针对社区的、多层次的策略来增强疫苗信心,以提高 HPV 和其他青少年疫苗的接种率。